Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...
The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.
Dr David Johnson selects his 10 highest-impact publications from 2025, which define new management standards across a broad spectrum of diseases.
The main market opportunities lie in developing comprehensive training and support services for implementing and integrating clinical quality management systems (CQMS) that align with evolving ...
The market opportunity lies in providing training and tools for EU RMP compliance, focusing on creating and updating RMPs per regulatory standards. Key services include offering practical guidance on ...
Revised version global guidelines on diverticular disease of the colon: the Fiesole Consensus report
Introduction Colonic diverticulosis is the most common structural abnormality of the colon in developed countries, with an increasing global prevalence. Approximately 20–25% of affected individuals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback